COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Food and Drug Administration late last night amended Pfizer’s emergency use authorization for its COVID-19 vaccine to allow for an additional, booster dose for certain individuals. FDA will authorize a booster shot to be administered six months following a completed two-dose regiment for the…
The Food and Drug Administration authorized administering the monoclonal antibodies bamlanivimab and etesevimab together to prevent COVID-19 in certain children and adults exposed to SARS-CoV-2 who are not fully vaccinated against COVID-19 and at high-risk for progressing to severe disease.
The Food and Drug Administration alerted clinical laboratory staff and health care providers to the potential for false positive results with two test kits made by Abbott Molecular to detect SARS-CoV-2.
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee by a unanimous vote recommended that the FDA issue an emergency use authorization that would enable COVID-19 vaccine boosters for individuals age 65 and older and those at high risk for severe COVID-19,…
The AHA has received a $1 million grant from the Centers for Disease Control and Prevention to continue for one year its efforts to encourage COVID-19 vaccine confidence in the hospital field, clinicians and the public.
The Food and Drug Administration released updated enforcement policy related to face masks, barrier face coverings, face shields, surgical masks and respirators for the duration of the COVID-19 public health emergency.
The Centers for Disease Control and Prevention updated its guidance for health care personnel on preventing and controlling infections during the COVID-19 pandemic; managing health care personnel with SARS-CoV-2 infection or exposure; and preventing SARS-CoV-2 spread in nursing homes.
According to new Centers for Disease Control and Prevention research, hospitalization for COVID-19 for children and adolescents increased four-fold in August in states with low levels of vaccination, compared with states with high levels.
Team Strategies, Tools to Enhance Performance & Patient Safety to improve communication & teamwork in health care for colleagues, patients & families.
The Centers for Disease Control and Prevention alerted health care providers and the public to reports of severe illness associated with using products containing ivermectin to prevent or treat COVID-19.